Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Winner Nusantara Jaya Tbk. (WINR)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Winner Nusantara Jaya Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Winner Nusantara Jaya Tbk. diperdagangkan di Rp28 (kapitalisasi pasar 146,59 M, volume 24 jam 59,46 jt). Perbedaan utamanya: Winner Nusantara Jaya Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WINR | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 146,59 M |
Volume | — | 59,46 jt |
Lot | — | 594,59 rb |
Perputaran | — | 1,59 M |
Harga Rata-rata | — | 26,78 |
Nilai Transaksi | — | 1,59 M |
Harga Ekuilibrium Indikatif | — | 28 |
Volume Ekuilibrium Indikatif | — | 166,31 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Winner Nusantara Jaya Tbk.
PT Winner Nusantara Jaya Tbk (the Company) was established based on notarial deed No. 10 dated October 10, 2007 of Anly Cenggana, S.H., notary in Batam.
Selengkapnya di halaman WINR →
